These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7788735)
1. [Expression of c-erbB-2 protein and EGF receptor in hepatitis B, cirrhosis and hepatocellular carcinoma]. Su Q; Liu Y Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):93-5. PubMed ID: 7788735 [TBL] [Abstract][Full Text] [Related]
2. [Expression of c-myc, c-erbB-2, insulin-like growth factor II andepidermal growth factor receptor in hepatitis B, cirrhosis and hepatocellular carcinoma]. Su Q; Liu Y Zhonghua Yi Xue Za Zhi; 1995 Mar; 75(3):144-6, 189. PubMed ID: 7780818 [TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer. Liu J; Ahiekpor A; Li L; Li X; Arbuthnot P; Kew M; Feitelson MA Int J Cancer; 2009 Oct; 125(8):1894-901. PubMed ID: 19610068 [TBL] [Abstract][Full Text] [Related]
5. [Expression of p21 in hepatocellular carcinoma and liver cirrhosis and its relation with HBV infection]. Ren CS Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):88-90. PubMed ID: 1655296 [TBL] [Abstract][Full Text] [Related]
6. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma. Seo JH; Kim KW; Murakami S; Park BC J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091 [TBL] [Abstract][Full Text] [Related]
7. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma. Seo JH; Park BC Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease. Yusof YA; Yan KL; Hussain SN Anal Quant Cytol Histol; 2003 Dec; 25(6):332-8. PubMed ID: 14714299 [TBL] [Abstract][Full Text] [Related]
10. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis. Badawy AA; El-Hindawi A; Hammam O; Moussa M; Gabal S; Said N APMIS; 2015 Oct; 123(10):823-31. PubMed ID: 26279457 [TBL] [Abstract][Full Text] [Related]
11. [The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis]. Shen LJ; Guo W; Gao P; Yu J; Qian ZY; Zhang HX; Zhang ZJ Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):227-30. PubMed ID: 22475145 [TBL] [Abstract][Full Text] [Related]
12. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study. Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139 [TBL] [Abstract][Full Text] [Related]
13. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma. Park BC; Huh MH; Seo JH J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479 [TBL] [Abstract][Full Text] [Related]
15. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases. Felipe-Silva A; Wakamatsu A; Dos Santos Cirqueira C; Alves VA World J Gastroenterol; 2016 Jul; 22(27):6246-56. PubMed ID: 27468214 [TBL] [Abstract][Full Text] [Related]
17. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development. Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481 [TBL] [Abstract][Full Text] [Related]
18. [Comparative study of the expression of IGF-2 and HBxAg in human hepatocellular carcinoma and liver cirrhosis]. Zhang JF; Liu YF; Su Q Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):282-4. PubMed ID: 7874760 [TBL] [Abstract][Full Text] [Related]
20. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma. Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]